Showing posts with label Meridian Bioscience. Show all posts
Showing posts with label Meridian Bioscience. Show all posts

Wednesday, February 1, 2012

Yara (YARIY) (VIVO) (ZFSVY) (AON) (CIB) (AIXG) Ratings, Price Targets

Yara International ASA (NASDAQ: YARIY), Meridian Bioscience, Inc. (NASDAQ: VIVO), Zurich Financial Services (NASDAQ: ZFSVY), Aon Co. (NYSE: AON), Bancolombia S.A. (NYSE: CIB) and Aixtron AG (NASDAQ: AIXG) ratings and price targets.

Meridian Bioscience, Inc. (VIVO) was downgraded by Wedbush from a “Neutral” rating to an “Underperform” rating.

Yara International ASA (YARIY) was downgraded by Credit Suisse (NYSE:CS) from an “Outperform” rating to a “Neutral” rating.

Zurich Financial Services (ZFSVY) was downgraded by JPMorgan Chase & Co. (NYSE:JPM) from an “Overweight” rating to a “Neutral” rating.

Aon Co. ( AON) was upgraded by Credit Suisse (NYSE:CS) from an “Underperform” rating to a “Neutral” rating. They have a price target of $50.00 on the company.

Bancolombia S.A. (CIB) was upgraded by Raymond James (NYSE:RJF) to an “Outperform” rating.

BNP Paribas initiated coverage on Aixtron AG (AIXG). They placed an “Underperform” rating on the company.

Tuesday, May 10, 2011

Coverage on (TRGP) (VIVO) (VRX) (VVC) Initiated

Coverage on Targa Resources Investments Inc (NASDAQ: TRGP), Meridian Bioscience, Inc. (NASDAQ: VIVO), Valeant Pharmaceuticals (NYSE: VRX) and Vectren Corporation (NYSE: VVC) initiated by analysts.

Credit Suisse (NYSE:CS) initiated coverage on Targa Resources Investments Inc (TRGP). They placed a “neutral” rating on the company.

Sidoti initiated coverage on Meridian Bioscience, Inc. (VIVO). They placed a “neutral” rating and a price target of $25.00 on the company.

Goldman Sachs (NYSE:GS) initiated coverage on Valeant Pharmaceuticals (VRX). They placed a “neutral” rating and a price target of $50.00 on the company.

Wells Fargo & Co. (NYSE:WFC) initiated coverage on Vectren Corporation (VVC). They placed a “market perform” rating on the company.